Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Prediction of coronary heart disease using risk factor categories.Circulation. 1998; 97: 1837-1847
- Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report.Circulation. 2002; 106: 3143-3421
- Validation of the Framingham coronary heart disease prediction scores.JAMA. 2001; 286: 180-187
- Prevention of coronary heart disease in clinical practice.Atherosclerosis. 1998; 140: 199-270
- Joint British recommendations on prevention of coronary heart disease in clinical practice.Heart. 1998; 80: S1-S29
- Prevention conference V. Beyond secondary prevention.Circulation. 2000; 101: e3-e11
- Prevention conference V. Beyond secondary prevention.Circulation. 2000; 101: 111-116
- Lifetime risk for coronary heart disease by cholesterol levels at selected ages.Arch Intern Med. 2003; 163: 1966-1972
- Lifetime risk of developing coronary heart disease.Lancet. 1999; 353: 89-92
- Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women.Arch Intern Med. 1989; 149: 2445-2448
- Effect of risk factor values on lifetime risk of and age at first coronary event. The Adventist Health Study.Am J Epidemiol. 1995; 142: 746-758
- An approach to longitudinal studies in a community.Ann NY Acad Sci. 1963; 107: 539-556
- The Framingham Offspring Study. Design and preliminary data.Prev Med. 1975; 4: 518-525
Abbott RD, McGee DL. The Framingham Study: an epidemiological investigation of cardiovascular disease, section 37: the probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics. Bethesda, MD: National Heart, Lung and Blood Institute, 1987
SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute, Inc., 1999
- Lifetime risk of dementia and Alzheimer's disease.Neurology. 1997; 49: 1498-1504
- Residual lifetime risk for developing hypertension in middle-aged women and men.JAMA. 2002; 287: 1003-1010
- Nonparametric estimation from incomplete observations.J Am Stat Assoc. 1958; 53: 457-481
- On the use of cause-specific failure and conditional failure probabilities.J Am Stat Assoc. 1993; 88: 402-409
☆Dr. Lloyd-Jones is supported by grant 1 K23 HL04253 from the National Institutes of Health, Bethesda, Maryland. The Framingham Heart Study is supported by contract N01-HC-25195 from the National Institutes of Health/National Heart, Lung, and Blood Institute, Bethesda, Maryland.